9 Meters Biopharma (NMTR) Files for Bankruptcy, Ceases Operations

On July 17, 2023, after considering all strategic alternatives, 9 Meters Biopharma (NASDAQ: NMTR), together with its subsidiaries, ceased operations and filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the Eastern District of North Carolina Case No. 23-01992-5-PWM (the “Bankruptcy Filing”). A Chapter 7 trustee will be appointed by the Bankruptcy Court and will assume control over the assets and liabilities of the Company, effectively eliminating the authority and powers of the Board of Directors of the Company and its executive officers to act on behalf of the Company. The assets of the Company will be liquidated and claims paid in accordance with the Bankruptcy Code.

You May Also Be Interested In

• Exchange Bank declares Q3 dividend, CEO to retire in 2027
• Faraday Future reports record Q2 revenue, cuts debt by $100M
• J.M. Smucker names Jeff Varcoe as SVP of Science and Technical